Cerianna

Chemical Namefluoroestradiol F-18
Dosage FormInjection (intravenous;148 MBq/mL to 3,700 MBq/mL)
Drug ClassRadioactive agents
SystemFemale reproductive
CompanyZionexa
Approval Year2020

Indication

  • Indicated for use with positron emission tomography (PET) imaging for the detection of estrogen receptor (ER)-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer.
Last updated on 12/9/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Cerianna (fluoroestradiol F-18) Prescribing Information.2020Zionexa US Corp